{"log_id": 750530806129959758, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 0, "average": 0.985134, "min": 0.985134}, "location": {"width": 40, "top": 144, "height": 19, "left": 748}, "words": " CZR"}, {"probability": {"variance": 0.000448, "average": 0.995773, "min": 0.865954}, "location": {"width": 844, "top": 199, "height": 79, "left": 207}, "words": "对于双侧肾动脉狭窄或只有单侧肾脏而肾动脉狭窄的病人,影响肾素一血管紧张素系统的"}, {"probability": {"variance": 0.000273, "average": 0.996406, "min": 0.892599}, "location": {"width": 887, "top": 240, "height": 84, "left": 166}, "words": "其他药物可增加其血尿素和血清肌酐含量。使用本品也有类似的报导。停止治疗后,这些肾功"}, {"probability": {"variance": 1e-06, "average": 0.999264, "min": 0.996936}, "location": {"width": 174, "top": 327, "height": 37, "left": 169}, "words": "能的变化可以恢复"}, {"probability": {"variance": 1.1e-05, "average": 0.9968, "min": 0.990579}, "location": {"width": 233, "top": 363, "height": 43, "left": 172}, "words": "[孕妇及哺乳期妇女用药]"}, {"probability": {"variance": 0.000568, "average": 0.994498, "min": 0.84876}, "location": {"width": 843, "top": 408, "height": 78, "left": 216}, "words": "当孕妇在怀孕中期和后期用药时,直接作用于肾素一血管紧张素系统的药物可引起正在发"}, {"probability": {"variance": 3e-05, "average": 0.994501, "min": 0.987405}, "location": {"width": 85, "top": 416, "height": 27, "left": 177}, "words": "孕妇用药"}, {"probability": {"variance": 0.000122, "average": 0.995798, "min": 0.94187}, "location": {"width": 582, "top": 468, "height": 60, "left": 177}, "words": "育的胎儿损伤,甚至死亡。当发现怀孕时,应该尽早停用本品"}, {"probability": {"variance": 1.1e-05, "average": 0.997853, "min": 0.986994}, "location": {"width": 846, "top": 491, "height": 77, "left": 218}, "words": "尽管没有怀孕妇女使用本品的经验,但使用氯沙坦钾进行的动物研究已证明有胎儿及新生"}, {"probability": {"variance": 0.00142, "average": 0.992411, "min": 0.75606}, "location": {"width": 885, "top": 535, "height": 76, "left": 182}, "words": "儿损伤和死亡,其机制被认为是通过药物介导而对肾素一血管紧张素系统作用所致。人类胎儿"}, {"probability": {"variance": 0.002909, "average": 0.990275, "min": 0.649306}, "location": {"width": 885, "top": 573, "height": 80, "left": 182}, "words": "从怀孕中期开始的肾灌注,取决于肾素一血管紧张素系统的发育,因此,如果在怀孕的中期和"}, {"probability": {"variance": 3e-05, "average": 0.997468, "min": 0.976854}, "location": {"width": 349, "top": 645, "height": 49, "left": 185}, "words": "后期应用本品,对胎儿的危险会增加"}, {"probability": {"variance": 1.3e-05, "average": 0.99825, "min": 0.980435}, "location": {"width": 844, "top": 697, "height": 76, "left": 231}, "words": "尚不知道氯沙坦是否经人乳分泌。由于许多药物可经人乳分泌,而对哺乳婴儿产生不良作"}, {"probability": {"variance": 8e-06, "average": 0.997889, "min": 0.991372}, "location": {"width": 152, "top": 698, "height": 33, "left": 188}, "words": "哺乳期妇女用药"}, {"probability": {"variance": 6e-06, "average": 0.998778, "min": 0.988208}, "location": {"width": 629, "top": 751, "height": 66, "left": 189}, "words": "用,故应该从对母体重要性的考虑来决定是停止哺乳还是停用药物"}, {"probability": {"variance": 0.000117, "average": 0.986243, "min": 0.970861}, "location": {"width": 109, "top": 824, "height": 29, "left": 193}, "words": "[儿童用药]"}, {"probability": {"variance": 0.000249, "average": 0.994987, "min": 0.910864}, "location": {"width": 801, "top": 821, "height": 72, "left": 279}, "words": "已经在年龄>1个月至16岁的高血压儿童中建立本品的抗高血压作用。来自于足够的"}, {"probability": {"variance": 5e-06, "average": 0.998363, "min": 0.990759}, "location": {"width": 821, "top": 866, "height": 75, "left": 197}, "words": "儿童及成人对照研究和在儿童中使用的文献报道的证据都支持本品在这些年龄组的运用"}, {"probability": {"variance": 8e-06, "average": 0.99832, "min": 0.986841}, "location": {"width": 843, "top": 905, "height": 74, "left": 239}, "words": "对50例高血压儿童,年龄在>1个月至<16岁,每天一次口服氯沙坦剂量约为0.54"}, {"probability": {"variance": 0.004328, "average": 0.979778, "min": 0.614432}, "location": {"width": 887, "top": 945, "height": 78, "left": 198}, "words": "0.77mg/Kg(平均剂量),进行氯沙坦的药代动力学研究。在所有年龄组,氯沙坦均形成活性"}, {"probability": {"variance": 2.5e-05, "average": 0.998087, "min": 0.974907}, "location": {"width": 885, "top": 987, "height": 76, "left": 204}, "words": "代谢物。总的说来,氯沙坦和它的活性代谢物的药代动力学在所研究的各年龄组之间相似,与"}, {"probability": {"variance": 0.002217, "average": 0.985033, "min": 0.815601}, "location": {"width": 305, "top": 1059, "height": 45, "left": 205}, "words": "已有的成人药代动力学数据一致"}, {"probability": {"variance": 0.001741, "average": 0.987191, "min": 0.788665}, "location": {"width": 845, "top": 1070, "height": 72, "left": 248}, "words": "一项由177例年龄在6-16岁的高血压儿童参加的临床研究,体重≥20Kg至<50Kg的病"}, {"probability": {"variance": 0.000223, "average": 0.994408, "min": 0.906228}, "location": {"width": 884, "top": 1110, "height": 77, "left": 208}, "words": "人,每天服用2.5,25或50mg的氯沙坦,体重≥50Kg的病人每天服用5,50或100mg的氯"}, {"probability": {"variance": 1.7e-05, "average": 0.997736, "min": 0.982748}, "location": {"width": 865, "top": 1152, "height": 77, "left": 208}, "words": "沙坦。每天一次服用可降低谷值血压,并呈剂量相关性。在所有的亚组人群(例如:年龄"}, {"probability": {"variance": 2.8e-05, "average": 0.997088, "min": 0.973568}, "location": {"width": 812, "top": 1196, "height": 75, "left": 211}, "words": " Tanner分期,性别,种族)均观察到氯沙坦的剂量相关性。然而所研究的最低剂量"}, {"probability": {"variance": 0.001113, "average": 0.989068, "min": 0.810763}, "location": {"width": 822, "top": 1242, "height": 70, "left": 215}, "words": "和5mg,相当于平均每天0.7mg/g的剂量,并没有表现出与其他剂量一致的抗高血压"}, {"probability": {"variance": 0.011559, "average": 0.891036, "min": 0.783524}, "location": {"width": 88, "top": 1220, "height": 49, "left": 1040}, "words": "确有"}, {"probability": {"variance": 0, "average": 0.915578, "min": 0.915578}, "location": {"width": 53, "top": 1250, "height": 48, "left": 1120}, "words": "袋"}, {"probability": {"variance": 4e-06, "average": 0.998761, "min": 0.992082}, "location": {"width": 350, "top": 1305, "height": 47, "left": 216}, "words": "在这项研究中,本品通常耐受性良好"}, {"probability": {"variance": 0.000589, "average": 0.988749, "min": 0.891559}, "location": {"width": 847, "top": 1319, "height": 72, "left": 259}, "words": "对于能吞咽片剂,体重在≥20Kg至<50Kg的病人,推荐剂量为每天一次25mg。最大剂量"}, {"probability": {"variance": 0.001876, "average": 0.991653, "min": 0.705149}, "location": {"width": 884, "top": 1362, "height": 72, "left": 221}, "words": "可以增加到每天一次50mg。对于体重>50Kg的病人,起始剂量为每天一次50mg最大剂量可"}, {"probability": {"variance": 0.002512, "average": 0.720397, "min": 0.670273}, "location": {"width": 125, "top": 1412, "height": 30, "left": 987}, "words": " MAS ACA"}, {"probability": {"variance": 0.006182, "average": 0.973907, "min": 0.702135}, "location": {"width": 232, "top": 1436, "height": 41, "left": 221}, "words": "以增加到每天一次100mg"}, {"probability": {"variance": 1e-06, "average": 0.999276, "min": 0.994566}, "location": {"width": 589, "top": 1456, "height": 60, "left": 264}, "words": "对血管容量不足的儿童病人,在服用本品前应该纠正这些状况"}, {"probability": {"variance": 0.004926, "average": 0.965203, "min": 0.808802}, "location": {"width": 203, "top": 1468, "height": 46, "left": 941}, "words": "/杭州默沙东"}, {"probability": {"variance": 0.000554, "average": 0.989705, "min": 0.93209}, "location": {"width": 182, "top": 1509, "height": 54, "left": 974}, "words": "制药有限公司8"}], "language": 3}